Abstract:The advent of artificial intelligence (AI) has revolutionized neurological and neuropsychiatric research, offering powerful and efficient tools to analyze complex, multiomodal, and vast datasets that were previously intractable. Recent advancement of integrated Machine learning (ML) and deep learning (DL) algorithms have enabled researchers to uncover patterns and novel insights, advancing our understanding of neural mechanisms and wide range of disorders. This editorial introduces four recent research contributions that exemplify the transformative application of emerging AI-based technologies in this field, highlighting their substantial impact on diagnosis, treatment, and patient care. The finding of these advancements, and future work, will be an integral part of the future of personalized medicine, pushing the boundaries of what is possible in neurological and neuropsychiatric care. This study employs explainable ML models to identify key predictors of parenting stress and its subclasses among caregivers of children with autism spectrum disorder (ASD). The study analyzed data from 496 participants and utilized four different ML classifiers (eXtreme gradient boosting (XGBoost), support vector machine (SVM), logistic regression, and random forest (RF)). RF outperformed other classifiers for predicting parental distress, difficult child, and total parenting stress with area under the curve (AUC) values of 0.83, 0.81, 0.86, respectively, while SVM outperformed the rest for predicting parent-child dysfunctional interaction with AUC value of 0.81. Significant predictors included child-related factors like aggressive behavior and anxiety/depression, as well as caregiver-related factors such as depression and social introversion. The top five significant predictors for each subclass are listed in this study. The use of interpretable models offers valuable insights for clinicians to identify at-risk caregivers and provide timely interventions, ultimately improving outcomes for families affected by ASD.Paper 2: Generative Adversarial Networks in MRI-Based Diagnostic ClassificationThe second study provides a comprehensive review of the recent applications of generative models, particularly generative adversarial networks (GANs) in enhancing diagnostic classification of brain disorders using structural and functional MRI data. GANs effectively tackle challenges such as data scarcity and class imbalance by generating high-quality synthetic data to augment existing datasets, thereby significantly improving model robustness and performance. The review discusses the latest advancements in GAN architectures and highlights the need for standardized metrics to assess the quality of generated data. The authors suggest integrating GANs with graph convolutional networks (GCNs) and self-attention mechanisms to better capture complex brain network features, further enhancing diagnostic precision. They emphasize the importance of collaboration between method developers and end-users to tailor GAN applications effectively in real-world challenges in neuroimaging. The authors conduct an in-depth analysis of both biofluids and neuroimaging data to enhance the precision and reliability of cognitive impairment detection. Reviewing literature that applies ML algorithms to different biomarkers, from structural and functional MRI scans, positron emission tomography (PET), betaamyloid-42, tau proteins, the authors found that combining biofluid and imaging biomarkers enhances diagnostic accuracy, with some studies reporting AUC values above 0.90. The paper underscores the importance of proper model development protocols, noting that studies with rigorous methodologies tend to report higher capabilities. The findings suggest that integrating multiple biomarker types and adhering to robust training and testing procedures are crucial for developing reliable diagnostic tools.The fourth study presents a bibliometric analysis of research on the objective assessment of cognitive fatigue spanning from 2007 to 2023. Analyzing 1,094 articles, the study identifies key trends, influential contributors, and emerging hotspots; thus, offers a detailed map of the field's evolution. Modalities such as electroencephalogram (EEG), functional near-infrared spectroscopy (fNIRS), heart rate variability (HRV), electrooculography (EOG), and eye-tracking are highlighted as central tools for objective fatigue assessment. Additionally, the analysis reveals a growing interest in developing innovative deep neural networks and multimodal fusion techniques to significantly enhance detection accuracy. Future research is expected to focus on practical applications like monitoring fatigue in drivers and pilots, emphasizing the societal relevance ad real-world relevance of these advancements.Collectively, these articles highlight several emerging trends:• Explainable and interpretable AI models for precision diagnosis: Th -Abstract Truncated-

The Untapped Potential of Dimension Reduction in Neuroimaging: Artificial Intelligence-Driven Multimodal Analysis of Long COVID Fatigue

Leveraging Artificial Intelligence to Optimize Transcranial Direct Current Stimulation for Long COVID Management: A Forward-Looking Perspective

Neural Mechanisms of Mental Fatigue Revisited: New Insights from the Brain Connectome

Artificial Intelligence's Transformative Role in Illuminating Brain Function in Long COVID Patients Using PET/FDG

Editorial: Emerging artificial intelligence technologies for neurological and neuropsychiatric research

Multimodal active subspace analysis for computing assessment oriented subspaces from neuroimaging data

Long-term Neurological Sequelae in Post-COVID-19 Patients: A Machine Learning Approach to Predict Outcomes

Adaptive Multimodal Neuroimage Integration for Major Depression Disorder Detection

AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers -- A narrative review of a growing field

Understanding Cognitive Fatigue from fMRI Scans with Self-supervised Learning

Neuroimaging Correlates of Post-COVID-19 Symptoms: A Functional MRI Approach

Nonlinearity-aware Based Dimensionality Reduction and Over-Sampling for AD/MCI Classification from MRI Measures.

Multimodal Neuroimaging for Early Alzheimer's detection: A Deep Learning Approach

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning

Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

Interpreting Brain Biomarkers: Challenges and solutions in interpreting machine learning-based predictive neuroimaging

Multimodal Predictive Modeling: Scalable Imaging Informed Approaches to Predict Future Brain Health

MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum

Automatic Detection of Alzheimer's Disease using Deep Learning Models and Neuro-Imaging: Current Trends and Future Perspectives